Clinical Trial Update: Safety, Hemodynamic Effects and Efficacy of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intramuscular PDA-002 for diabetic foot ulcer with peripheral arterial disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer
• Peripheral Arterial Disease

Drugs mentioned

• PDA-002

Snippet

Sponsor: Celularity Incorporated | Conditions: Diabetic Foot, Peripheral Arterial Disease | Phase 2 | Status: WITHDRAWN